With regard to glioma, several nutritional and inflammatory biomarker scores, such as the Controlling Nutritional Status (CONUT) score, the Prognostic Nutritional Index (PNI), and hematologic biomarkers such as albumin or fibrinogen have been established to predict OS in glioma patients [22]. This evidence concerns the gene ALB and central nervous system cancer.